Cystic fibrosis: cystic fibrosis transmembrane conductance regulator and cystic fibrosis disease Cystic fibrosis (CF) is a progressive disease affecting over 70,000 people globally and 30,000 people in the United States [Cystic Fibrosis Foundation, 2011; Pilewski et al. 1999; Rowe et al. 2005, Rogan et al. 2011]. CF is caused by autosomal recessive mutations in the gene coding for the CF transmembrane conductance regulator (CFTR) protein, and approximately 1900 disease-causing CFTR mutations have been described since its discovery (http://www.genet. sickkids.on.ca/cftr/app). CFTR is an anion channel and traffic ATPase, and members of this protein family typically have two transmembrane domains that anchor the protein in the plasma membrane and two cytoplasmic nucleotide binding domains (NBD-1 and-2). Gating of CFTR is provided by the two NBDs, which come together in a heterodimer complex to bind and hydrolyze adenosine triphosphate (ATP)